Latest Incyte News & Updates
See the latest news and media coverage for Incyte. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global biopharmaceutical company
incyte.com- Headquarters
- Wilmington, United States
- Company type
- Public company
- Number of employees
- 3,000–5,000
Latest news about Incyte
Company announcements
-
Incyte appoints Suketu Upadhyay as CFO
He brings extensive healthcare experience and a strong track record in leading finance organizations.
-
Incyte announces FDA approval of Jakafi XR
The once-daily extended-release tablets treat myelofibrosis, polycythemia vera, and graft-versus-host disease. Availability starts May 8.
-
Incyte appoints Suketu Upadhyay as CFO
Effective May 4, 2026, he will lead global finance, strategic planning, and investor relations. Upadhyay brings extensive experience from Zimmer Biomet and Bristol Myers Squibb.
-
Incyte reports Q1 2026 financial results
Total revenue reached $1.27 billion, up 21% year-over-year. Net sales grew 20% to $1.10 billion. Pipeline advances include positive Phase 3 vitiligo data and new executive appointments.
Media coverage
-
Incyte's NIKTIMVO wins Australia cGVHD approval | INCY Stock News
AGAVE-201 showed a 74% response rate, with 60% maintaining response at 12 months, offering a new option after at least two prior therapies.
-
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with...
-
Earnings Beat: Incyte Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
A week ago, Incyte Corporation (NASDAQ:INCY) came out with a strong set of quarterly numbers that...
-
FDA warns three firms for GMP violations, cites Incyte for misleading claims
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for noncompliance with current good...
Track Incyte and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Incyte competitors & trending companies
Browse news for competitors to Incyte and other trending companies.